US Patent Number
5508305
Publication Date
4-16-1996
Abstract
2,4-disulfonyl α-phenyl-tert-butyl nitrone and its pharmaceutically acceptable salts are disclosed. These materials are useful as pharmaceutical agents for oral or parenteral, e.g. intravenous administration to patients suffering from acute central nervous system oxidation as occurs in a stroke or from gradual central nervous system oxidation which can exhibit itself as progressive central nervous system function loss. The materials are also used to ameliorate the side effects of oxidative-damage causing antineoplastic disease treatments.
Assignees
Oklahoma Medical Research Foundation, Oklahoma City, Okla., University of Kentucky Research Foundation, Lexington, Ky.
Application Number
468,564
Filing Date
06/06/1995
Recommended Citation
Carney, John M., "2,4-Disulfonyl Phenyl Butyl Nitrone, Its Salt and Their Use as Pharmaceuticals" (1996). Pharmacology and Nutritional Sciences Faculty Patents. 26.
https://uknowledge.uky.edu/pharmacol_patents/26
